UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000006819 |
|---|---|
| Receipt number | R000008063 |
| Scientific Title | Multicenter Phase II Study of FOLFIRI and biweekly Cetuximab combination chemotherapy as First Line Therapy in Patients with Wild Type KRAS Metastatic Colorectal Cancer. ( FIRBIC ) |
| Date of disclosure of the study information | 2011/12/01 |
| Last modified on | 2019/02/14 14:37:55 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2011/12/01 21:11:56 | ||
| 2 | Update | 2019/02/14 14:36:37 | Address Address TEL Address Address TEL Address Address TEL Name of primary person or sponsor Organization Address1 Tel1 |
|
| 3 | Update | 2019/02/14 14:37:55 | Recruitment status |
